Team Evaluation of VIM ELISA Kit in Brain Cancer Research Vimentin, a key intermediate filament protein, has emerged as a significant biomarker in the context of brain cancer due to its involvement in tumor progression and metastasis. Enzyme-Linked Immunosor... Jun 10, 2024 AffiELISA®
Team Evaluation of VEGFB Expression in Brain Cancer Using ELISA Kit Vascular endothelial growth factor B (VEGFB) is a member of the VEGF family that plays a crucial role in angiogenesis and vascular permeability. Dysregulation of VEGFB expression has been implicated i... Jun 10, 2024 AffiELISA®
Team Quantification of Vascular Endothelial Growth Factor A (VEGFA) Levels in Brain Cancer Using ELISA Assay: A Technical Approach Vascular endothelial growth factor A (VEGFA) is a key regulator of angiogenesis, contributing significantly to the pathogenesis and progression of brain cancer. Quantification of VEGFA levels in brain... Jun 10, 2024 AffiELISA®
Team Detailed Analysis of TNFSF9 ELISA Kit Utilization in Brain Cancer Research TNFSF9, also known as CD137 ligand (CD137L) or 4-1BB ligand (4-1BBL) , is a crucial member of the tumor necrosis factor (TNF) superfamily. It plays a significant role in the immune system, particularl... Jun 10, 2024 AffiELISA®
Team Detection of TNFRSF1A Expression in Brain Cancer Using ELISA Kit: A Technical Approach Tumor necrosis factor receptor superfamily member 1A (TNFRSF1A) plays a pivotal role in mediating various cellular processes, including inflammation and apoptosis. Dysregulation of TNFRSF1A has been i... Jun 10, 2024 AffiELISA®
Team Development and Application of a PDCD1 Elisa Kit for Brain Cancer Research Programmed cell death protein 1 (PDCD1), also known as PD-1, has emerged as a critical regulator of immune responses in various cancers, including brain cancer. In this study, we describe the developm... Jun 10, 2024 AffiELISA®
Team Assessing IL2RA Expression in Brain Cancer: A Technical Guide to ELISA Analysis Interleukin-2 receptor subunit alpha (IL2RA) has emerged as a potential biomarker in brain cancer, with implications for prognosis and treatment response. Enzyme-linked immunosorbent assay (ELISA) rep... Jun 10, 2024 AffiELISA®
Team A Comprehensive Technical Manual for ERBB3 ELISA Assay in Brain Cancer Research The ERBB3 receptor, a member of the epidermal growth factor receptor (EGFR) family, has been implicated in various cancers, including brain cancer. Quantification of ERBB3 expression is crucial for un... Jun 10, 2024 AffiELISA®
Team Precision Quantification of CD47 in Brain Cancer: Insights from ELISA Analysis In the realm of brain cancer research, the investigation of CD47 expression levels has emerged as a pivotal area of interest due to its implications in tumor evasion from the immune system. Enzyme-lin... Jun 10, 2024 AffiELISA®
Team Quantification of CD274 Expression in Glioblastoma Multiforme: Applications of CD274 ELISA in Immunotherapeutic Strategies Glioblastoma multiforme (GBM) represents one of the most aggressive forms of primary brain tumors, characterized by high mortality rates and limited treatment options. Recent advancements in immunothe... Jun 10, 2024 AffiELISA®
Team Utilization of ANGPT2 Elisa Kit for the Treatment of Brain Cancer: A Scientific Investigation Brain cancer, particularly glioblastoma multiforme (GBM), remains a formidable challenge in oncology due to its aggressive nature and limited treatment options. Angiopoietin-2 (ANGPT2), a key regulato... Jun 10, 2024 AffiELISA®
Team Development and Validation of a Novel ELISA Kit for Quantification of Human T-lymphotropic Virus 2 (HTLV-2) p24 Capsid Protein The Human T-lymphotropic virus 2 (HTLV-2) is an oncogenic retrovirus primarily associated with T-cell malignancies and neurological disorders. The p24 capsid protein of HTLV-2 plays a crucial role in ... May 30, 2024 AffiELISA®